162 results
Page 2 of 9
8-K
EX-99.1
gfp770brnp9hw5 q549
9 Nov 22
Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point
4:07pm
8-K
EX-99.1
zqhgj04a1mdd
19 Oct 22
Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody
6:59am
8-K
EX-99.1
3j8btckrd0syb
3 Aug 22
Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance
4:07pm
DEFA14A
gmj8 1mjdf8
15 Jul 22
Additional proxy soliciting materials
4:09pm
DEFA14A
29s7z019 43ho
7 Jul 22
Additional proxy soliciting materials
4:18pm
DEFA14A
zc3zdh
17 Jun 22
Additional proxy soliciting materials
4:09pm
8-K
EX-99.1
u78pr1s8tg3y
4 May 22
Jazz Pharmaceuticals and Sumitomo Pharma Announce Exclusive License Agreement to Develop and Commercialize DSP-0187, a Potent, Highly Selective Oral Orexin-2 Receptor Agonist
4:17pm
8-K
EX-99.1
gke 7bm0sapafbsbb
4 May 22
Jazz Pharmaceuticals Announces First Quarter 2022
4:13pm
8-K
EX-99.1
6bjlya an
7 Apr 22
Other Events
7:15am
8-K
EX-99.1
jfu4gbgj8ilx8
28 Mar 22
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi® (solriamfetol) to Axsome Therapeutics
8:55am
8-K
EX-99.1
6cs1coyh
1 Mar 22
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2021
4:07pm
8-K
EX-99.1
k7zjj0gae jfkdfz
10 Jan 22
Announces $5 billion revenue target for 2025
7:47am
8-K
EX-99.1
pimc2m9x
9 Nov 21
Jazz Pharmaceuticals Announces Third Quarter 2021
4:07pm